Panels of custom-screened mAbs delivered against a wide variety of target types. Difficult targets are welcome. If we are not successful, you do not pay full price.
Our DiversimAb platform has shown to be very effective in delivering on anti-id projects with demanding specificity requirements. Delivery time is rapid, usually 60 days from start to delivery of screened hybridomas you’ve had the opportunity to test.
The limiting factor in most in-vivo antibody discovery platforms is the diversity of the immune response of the host animal. Abveris uses a proprietary rodent that has been engineered to express a more diverse antibody repertoire than regular animals. This enables the discovery of antibodies with specificities that cannot be found in other in-vivo systems.
Speed saves you time and money. The sooner you get the antibody you need, the sooner you can get to work. That’s why we to trim time from the antibody discovery timeline.
We’re a custom shop and all of our customers have their own unique mAb discovery and process needs. It’s our pleasure to fit into your workflow and your custom needs.
Talk to our team so we can understand your goals and design a workflow to maximize chances of success.
Proteins, cells, peptides, small molecules, DNA
We produce and custom-screen for hybridomas producing desired mAbs.
As little as 45 days after immunizations begin we provide screened hybridoma supernatant samples for testing.
We subclone and deliver selected hybridomas as well as purified antibody.